PDT Partners’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-26,415
Closed -$1.16M 954
2022
Q3
$1.16M Buy
26,415
+4,895
+23% +$237K 0.18% 182
2022
Q2
$1.06M Buy
+21,520
New +$1.15M 0.09% 380
2018
Q3
Sell
-87,101
Closed -$4.54M 553
2018
Q2
$4.54M Buy
87,101
+14,458
+20% +$757K 0.17% 164
2018
Q1
$3.79M Buy
+72,643
New +$3.68M 0.13% 190
2015
Q4
Sell
-13,798
Closed -$665K 1035
2015
Q3
$665K Sell
13,798
-19,702
-59% -$1.02M 0.01% 833
2015
Q2
$1.59M Buy
+33,500
New +$1.57M 0.04% 532

Other funds holding NUVA

PDT Partners's NUVA Position: Q4 2022 in Review

PDT Partners sold out of NuVasive, Inc. (NUVA) in Q4 2022, closing a stake of 26,415 shares — an estimated $1.16M sold.

PDT Partners first reported a position in NUVA in Q2 2015 and held it in 6 quarters. The position peaked at $4.54M in Q2 2018. 235 funds tracked by Wall St. Rank hold NUVA as of Q4 2022.

  • PDT Partners reported no remaining NuVasive, Inc. position as of Q4 2022 after selling out during the quarter.
  • PDT Partners sold 26,415 NuVasive, Inc. shares in Q4 2022, an estimated $1.16M.
  • PDT Partners first reported a position in NuVasive, Inc. in Q2 2015 and held it in 6 quarters.
  • PDT Partners's NuVasive, Inc. position peaked at $4.54M in Q2 2018.
  • 235 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2022.

Based on PDT Partners's 13F filing for Q4 2022, filed 14 Feb 2023.